Condition: Emphysema or COPD · Emphysema · Emphysema, Pulmonary · Sponsor: Morair Medtech, LLC
The goal of this clinical trial is to learn if bronchoscopic lung volume reduction with endobronchial thermal liquid ablation (ETLA) works to treat severe emphysema in terms of feasibility and safety. Participants will: * Have up to two ETLA procedures * Complete five clinic follow-up visits and two virtual follow-up visits.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Universitätsklinikum Allgemeines Krankenhaus Wien | Vienna, Austria, Austria | Not Yet Recruiting |
| Klinik Floridsdorf | Vienna, Austria, Austria | Recruiting |
| Gemeinschaftskrankenhaus Havelhöhe gGmbH Klinik für Anthroposophische Medizin | Berlin, Germany, Germany | Recruiting |
| Asklepios Lungenklinik Gauting GmbH | Gauting, Germany, Germany | Not Yet Recruiting |
| Asklepios Klinik Barmbek | Hamburg, Germany, Germany | Not Yet Recruiting |
| Thoraxklinik University of Heidelberg | Heidelberg, Germany, Germany | Not Yet Recruiting |
| University Medical Center Groningen | Groningen, The Netherlands, Netherlands | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06655428